Press Releases :: BIONIK Laboratories Corp. (BNKL)

BIONIK Laboratories Announces Third Quarter Fiscal 2020 Financial Results

Feb 14, 2020

BIONIK Laboratories Announces Regulatory Approval and First Sale of its InMotion® ARM Robotic Technology by its Exclusive Distributor in South Korea

Jan 30, 2020

BIONIK Laboratories Selects Propel to Accelerate New Product Development and Manufacturing of InMotion Robotic Systems and Services

Dec 10, 2019

BIONIK Laboratories Announces Second Quarter Fiscal 2020 Financial Results

Nov 15, 2019

BIONIK Laboratories Partners with Intelliware Development to Provide Seamless Connectivity Between InMotion™ Robotic Devices and Hospital Information Systems

Oct 14, 2019

BIONIK Laboratories Appoints Loren Wass as Chief Commercial Officer

Sep 4, 2019

BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

Aug 13, 2019

BIONIK Laboratories’ Fiscal 2019 Financial Results Feature 229% Increase in Sales

Jul 2, 2019

Landmark RATULS Research Trial of Robot-Assisted Stroke Therapy Utilizes BIONIK’s InMotion Robotic Therapy Systems

May 28, 2019

BIONIK Laboratories Third Quarter Fiscal 2019 Financial Results Feature 256% Increase in Sales

Feb 11, 2019

Global Headquarters

483 Bay Street
Office N105
Toronto, ON M5G 2C9
Canada

Tel: 1.416.649.7887
info@bioniklabs.com

U.S. Headquarters

80 Coolidge Hill Road,
Watertown, MA 02472
United States

Tel: 1.617.926.4800
support@bioniklabs.com

© 2020 BIONIK